An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (52)
  • Training (0)
  • User case (2)
  • User meeting (1)
  • Webinar (4)
  • White paper (0)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (4)
  • Breast (3)
  • Gastro-intestinal (7)
  • Genito-urinary (2)
  • Gynecological (0)
  • Head and neck (23)
  • Hodgkin and Non-Hodgkin lymphoma (1)
  • Ocular (0)
  • Pediatric (1)
  • Reirradiation (1)
  • Sarcomas (0)
  • Thoracic (10)
  • Reset filters
  • (-) IMPT

Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.

03/03/2020
/ Publications
/
IMPT
Chemotherapy
VMAT

This study compared 46 IMPT and 259 VMAT patients acute toxicities and reported that IMPT was associated with lower PEG-tube placement (p = 0.001) and less...

Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies.

05/07/2020
/ Publications
/
Toxicity
Reirradiation
IMPT

Published in Seminar Radiation Oncology, this review article evaluated clinical data up-to-date on proton reirradiation for local and regional recurrence. As...

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation

10/12/2020
/ Publications
/
VMAT
IMPT

A cohort of 30 patients was retrospectively selected as "at-risk" of dose de-escalation due to the proximity of the target volumes to dose-limiting healthy...

Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.

05/04/2021
/ Publications
/
IMPT
IMRT

This MD Anderson study published in the Green Journal retrospectively compares patients with oropharyngeal cancer (OPC) who received IMRT (n = 429) and IMPT (n...

Lower doses to hippocampi and other brain structures for skull-base meningiomas with IMPT compared to photon therapy.

07/09/2019
/ Publications
/
IMPT
VMAT

This study systematically compared intensity modulated proton therapy (IMPT), non-coplanar volumetric modulated arc therapy (VMAT) and intensity modulated...

TORPEdO - Phase III Trial of IMPT Vs IMRT for Multi-toxicity Reduction in Oropharyngeal Cancer.

07/10/2019
/ Publications
/
IMPT
Chemotherapy
IMRT

This is the UK's first proton clinical trial. Published in the Clinical Oncology, this editorial provided the rational and the plan of the trial. It is a...

Early clinical outcomes of helical tomotherapy/IMPT combination in nasopharynx cancer.

07/07/2019
/ Publications
/
IMPT
Chemotherapy

A study from Korea evaluated the feasibility of combining helical Tomotherapy (HT) and intensity-modulated proton therapy (IMPT) in treating patients with...

The first prototype of spot-scanning proton arc treatment delivery.

03/05/2019
/ Publications
/
ARC therapy
IMPT

Published in the Green Journal, the Beaumont group reported the first prototype of spot-scanning arc treatment (SPArc) delivery on IBA Proteus®One. The brain...

Comparison of supine or prone crawl photon or proton breast and regional lymph node radiation therapy including the internal mammary chain.

03/03/2019
/ Publications
/
VMAT
IMPT

A planning study conducted by a group of collective researchers in Europe. For six left sided breast cancer patients, treatment plans were made using non...

Toxicity and Survival After IMPT Versus Passive Scattering PT for NSCLC.

10/10/2020
/ Publications
/
Toxicity
IMPT

This MD Anderson study compared toxicity profiles and clinical outcomes after IMPT versus PSPT for 139 patients with locally advanced NSCLC. Compared to the...

Pagination

  • Previous page ‹
    • Page 1
    • Current page 2
    • Page 3
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies